Experts Identify Top Reasons for Missed Biopharma Product Launch Forecasts
December 14th 2023An evolving payer and commercial landscape post-COVID-19 pandemic, increasing regulatory complexity, and the discovery of new treatments with smaller patient populations are all factors impacting the research, development, and launch of new pharmaceutical products.
SCOPE Europe 2023: Decreasing Burden in Data Collection
October 17th 2023In an interview at SCOPE Europe 2023 with Applied Clinical Trials Editor, Andy Studna, Tony Mikulaschek, VP, eCOA, IQVIA Technologies addresses what stakeholders should be thinking of in the data collection space moving forward.